SYROS PHARMACEUTICALS, INC. Total Long-Term Debt
SYROS PHARMACEUTICALS, INC. had Total Long-Term Debt of $40.51 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Debt
us-gaap:LongTermDebt · last filed 2022-11-14
- 2022-09-30: Long-term Debt $40.51M.
- 2022-06-30: Long-term Debt $40.63M.
- 2022-03-31: Long-term Debt $40.44M.
- 2021-12-31: Long-term Debt $40.00M.
| Period end | Long-term Debt |
|---|---|
| 2022-09-30 | $40.51M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $40.63M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $40.44M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $40.00M 10-K · filed 2022-03-15 |
| 2021-09-30 | $40.00M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $40.00M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $40.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $40.00M 10-K · filed 2021-03-04 |
| 2020-09-30 | $20.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $20.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $20.00M 10-Q · filed 2020-05-07 |